SEB Asset Management’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$357K Sell
9,091
-8,923
-50% -$345K ﹤0.01% 669
2026
Q2
$656K Sell
18,014
-22,518
-56% -$710K ﹤0.01% 637
2026
Q1
$1.14M Buy
+40,532
New +$1.33M ﹤0.01% 615

Other funds holding HRMY

SEB Asset Management's HRMY Position: Q3 2026 in Review

SEB Asset Management reduced its Harmony Biosciences (HRMY) stake by 50% in Q3 2026, selling an estimated $345K and leaving 9,091 shares worth $357K. The position accounts for ﹤0.01% of the portfolio, ranked #669.

SEB Asset Management first reported a position in HRMY in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.14M in Q1 2026. 345 funds tracked by Wall St. Rank hold HRMY as of Q3 2026.

  • SEB Asset Management held 9,091 shares of Harmony Biosciences worth $357K as of Q3 2026.
  • SEB Asset Management sold 8,923 Harmony Biosciences shares in Q3 2026, an estimated $345K.
  • Harmony Biosciences made up ﹤0.01% of SEB Asset Management's portfolio in Q3 2026, its #669 holding.
  • SEB Asset Management first reported a position in Harmony Biosciences in Q1 2026 and has held it in 3 quarters since.
  • SEB Asset Management's Harmony Biosciences position peaked at $1.14M in Q1 2026.
  • 345 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2026.

Based on SEB Asset Management's 13F filing for Q3 2026, filed 4 Nov 2026.